|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Combined analysis of Efficacy: The addition of bevacizumab to fluorouracil/ leucovorin improves survinal for patient with metastatic colorectat cancer显示文摘 | KABBINAVAR FF HAMBLETON J MASS RD | 2005 | J Clin Oncol2005，23，16： | 1 |
| 2 | Phase Ⅱ , randomized trial comparing bevacizumab plus fluorouracil (FU) /leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer 显示文摘 | Kabbinavar F Hurwitz H Fehrenbacher L | 2003 | J Clin Oncol2003，21，1： | 1 |
| 3 | Angiogenesis and angiogenic inhibitors in renal cell carcinoma 显示文摘 | Sawhney R Kabbinavar F | 2008 | Curr Urol Rep2008，9，1： | 1 |
| 4 | Bevacizttmab with or without erlotinib in metastatic renal cell carcinoma(RCC)显示文摘 | Bukowskl RM Kabbinavar F Figlin RA | 2006 | J Clin Oncol2006，24，18： | 1 |
| 5 | Phase Ⅱ,randomized trial comparing bevacizumab plus fluorouracil(FU)/leucovorin(LV) with FU/LV alone in patients with metastatic colorectal cancer显示文摘 | Kabbinavar F Hurwitz HI Fehrenbacher L | 2003 | J Clin Oncol2003，21，1： | 1 |
| 6 | Phase Ⅱ, randomized trial comparing bevacizumab plus fluorouracil ( FU )/leucovorin ( LV ) with FU/LV alone in patients with metastatic colorectal caner 显示文摘 | Kabbinavar F Hurwitz HI Fehrenbacher L | 2003 | J Clin Oncol2003，21，1： | 1 |
| 7 | Natural history of rising ser- um prostate -specific antigen in men with castrate nonmetastafic prostate cancer 显示文摘 | Smith M R Kabbinavar F Saad F | 2005 | J Clin Onco12005，23，13： | 1 |
| 8 | Overexpression of Akt2/protein kinase Bbeta leads to up-regulation of betal inte- grins, increased invasion, and metastasis of human breast and ovarian cancer cells显示文摘 | Arboleda M J Lyons J F Kabbinavar F F | 2003 | Cancer Res2003，63，1： | 1 |
| 9 | Addition of bevacizum- ab to bolus fluorouracil and leucovorin in first-line metastatic colorec- tal cancer: results of a randomized phase II thai显示文摘 | Kabbinavar FF Schulz J McCleod M | 2005 | J Clin Oncol2005，23，16： | 1 |
| 10 | Overexpression of Akt2 protein kinase beta leads to up-regulation of betal integrins increased invasion,and metastasis of human breast and ovarian cancer cells显示文摘 | Arboleda M J Lyons J F Kabbinavar F F | 2003 | Cancer Res2003，63，2： | 1 |
| 11 | Overexpression of AKT2/protein kinasebβ leads to up-regulation of β1 integrins,increased invasion,and metastasis of human breast and ovarian cancer cells显示文摘 | ARBOLEDA M J LYONS J F KABBINAVAR F F | | 0，，01： | 1 |
| 12 | Phase Ⅱ,randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer显示文摘 | Kabbinavar F Hurwitz H Fehrenbacher L | 2003 | J Clin Oncol2003，21，： | 1 |
| 13 | Overexpression of A KT2/protein kinase Bbeta leads to upregulation of betalintegrins,increased invasion,and metastasis of human breast and ovarian cancer cells显示文摘 | ARboleda MJ Lyons JF Kabbinavar FF | 2003 | Cancer Res2003，63，1： | 1 |
| 14 | Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials 显示文摘 | Kabbinavar FF Hurwitz HI Yi J | 2009 | J Clin Oncol2009，27，2： | 1 |
| 15 | Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of betal integrins,increased invasion,and metastasis of human breast and ovarian cancer cells显示文摘 | Arboleda MJ Lyons JF Kabbinavar FF | 2003 | Cancer Res2003，63，： | 1 |
| 16 | Combined analysis of ef- ficacy: the addition of bevacizumab to fluoronracil/leucovorin improves survival for patients with metastatic colorectal cancer显示文摘 | Kabbinavar F Hambleton J Mass R D | 2005 | J Gin Oncol2005，23，16： | 1 |
| 17 | The effect of antibody to vas- cular endothelial growth factor and cisplatin on the growth of lung tumors in nude mice显示文摘 | Kabbinavar FF Wong JT Ayala RE | 1995 | Proc Am Assoc Cancer Res1995，36，： | 1 |
| 18 | (2003) Phase II, ran- domized trial comparing bevacizumab plus fluorouracil (FU)/leueo- vorin (LV) with FU/LV alone in patients with metastatic cotorectal cancer显示文摘 | Kabbinavar F Hurwits H I Bergsland E | 2003 | J Clin Oneol2003，6065，： | 1 |
| 19 | Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracilbased regimens irrespective of baseline risk 显示文摘 | Kabbinavar F Irl C Zurlo A | 2008 | Oncology2008，75，34： | 1 |
| 20 | EGFR biomarker-selected randomized phase Ⅱ study of erlotinib(E)or intercalated E with carboplatin/paclitaxel(C/P)in chemo-naive advanced NSCLC显示文摘 | Camidgel DR Kabbinavar F Martins R | 2008 | J Thorac Oncol2008，3，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员